FDA proposes tightening restrictions on compounding three categories of drugs
The FDA is proposing to tighten its regulations on compounding three categories of drugs that the agency determined are too difficult to compound, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.